News Release

  1. February 21, 2019


    Publication regarding Imarikiren (SCO-272)250 KB

  2. November 30, 2018


    Pipeline Portfolio has been updated.

  3. May 11, 2018


    Announcement of Phase 2 trial results of Imarikiren (SCO-272) at the 55th ERA-EDTA CONGRESS236 KB

  4. October 27, 2017


    Announcement of Phase 1 study results of Imarikiren (SCO-272) at the 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics383 KB

  5. June 09, 2017


    The presentations about the results of SCO-272 Ph1 trial in 54th ERA-EDTA

  6. June 09, 2017

    Corporate Information

    Press conference and Press releases about launch of SCOHIA PHARMA, Inc.